EC 2.3.1.48 - acetyl- CoA:histone acetyltransferase

3D structures of EC 2.3.1.48 - histone acetyltransferase in Protein Data Bank

updated: 6 January 2022, 2:15

1. 1bob: Histone Acetyltransferase Hat1 from Saccharomyces Cerevisiae in Complex with Acetyl Coenzyme a
2. 1f68: Nmr Solution Structure of The Bromodomain from Human Gcn5
3. 3p1e: Crystal Structure of The Bromodomain of Human Crebbp in Complex with Dimethyl Sulfoxide (dmso)
4. 3p1d: Crystal Structure of The Bromodomain of Human Crebbp in Complex with N-methyl-2-pyrrolidone (nmp)
5. 3p1c: Crystal Structure of The Bromodomain of Human Crebbp in Complex with Acetylated Lysine
6. 1n72: Structure and Ligand of a Histone Acetyltransferase Bromodomain
7. 3kmr: Crystal Structure of Raralpha Ligand Binding Domain in Complex with an Agonist Ligand (am580) and a Coactivator Fragment
8. 1p4q: Solution Structure of The Cited2 Transactivation Domain in Complex with The P300 Ch1 Domain
9. 3ipu: X-ray Structure of Benzisoxazole Urea Synthetic Agonist Bound to The Lxr-alpha
10. 3ips: X-ray Structure of Benzisoxazole Synthetic Agonist Bound to The Lxr- Alpha
11. 3ipq: X-ray Structure of Gw3965 Synthetic Agonist Bound to The Lxr-alpha
12. 3io2: Crystal Structure of The Taz2 Domain of P300
13. 3i3j: Crystal Structure of The Bromodomain of Human Ep300
14. 3hvl: Tethered Pxr-lbd/src-1p Complexed with Sr-12813
15. 1qsm: Histone Acetyltransferase Hpa2 from Saccharomyces Cerevisiae in Complex with Acetyl Coenzyme a
16. 1qso: Histone Acetyltransferase Hpa2 from Saccharomyces Cerevisiae
17. 3h0a: Crystal Structure of Peroxisome Proliferator-activated Receptor Gamma (pparg) and Retinoic Acid Receptor Alpha (rxra) in Complex with 9-cis Retinoic Acid, Co-activator Peptide, and a Partial Agonist
18. 3gg3: Crystal Structure of The Bromodomain of Human Pcaf
19. 3g9e: Aleglitaar. a New. Potent, and Balanced Dual Ppara/g Agonist for The Treatment of Type II Diabetes
20. 3g8i: Aleglitazar, a New, Potent, and Balanced Ppar Alpha/gamma Agonist for The Treatment of Type II Diabetes
21. 3et3: Structure of Ppargamma with 3-[5-methoxy-1-(4-methoxy- Benzenesulfonyl)-1h-indol-3-yl]-propionic Acid
22. 3et1: Structure of Pparalpha with 3-[5-methoxy-1-(4-methoxy- Benzenesulfonyl)-1h-indol-3-yl]-propionic Acid
23. 1tot: Zz Domain of Cbp- a Novel Fold for a Protein Interaction Module
24. 3dwy: Crystal Structure of The Bromodomain of Human Crebbp
25. 1u2n: Structure Cbp Taz1 Domain
26. 3dr1: Side-chain Fluorine Atoms of Non-steroidal Vitamin D3 Analogs Stabilize Helix 12 of Vitamin D Receptor
27. 3dcu: Fxr with Src1 and Gsk8062
28. 3dct: Fxr with Src1 and Gw4064
29. 3ctb: Tethered Pxr-lbd/src-1p Apoprotein
30. 3bqd: Doubling The Size of The Glucocorticoid Receptor Ligand Binding Pocket by Deacylcortivazol
31. 3biy: Crystal Structure of P300 Histone Acetyltransferase Domain in Complex with a Bisubstrate Inhibitor, Lys-coa
32. 1wgs: Solution Structure of The Tudor Domain from Mouse Hypothetical Protein Homologous to Histone Acetyltransferase
33. 1wo3: Solution Structure of Minimal Mutant 1 (mm1): Multiple Alanine Mutant of Non-native Chance Domain
34. 1wo4: Solution Structure of Minimal Mutant 2 (mm2): Multiple Alanine Mutant of Non-native Chance Domain
35. 1wo5: Solution Structure of Designed Functional Finger 2 (dff2): Designed Mutant Based on Non-native Chance Domain
36. 1wo6: Solution Structure of Designed Functional Finger 5 (dff5): Designed Mutant Based on Non-native Chance Domain
37. 1wo7: Solution Structure of Designed Functional Finger 7 (dff7): Designed Mutant Based on Non-native Chance Domain
38. 1wug: Complex Structure of Pcaf Bromodomain with Small Chemical Ligand Np1
39. 1wum: Complex Structure of Pcaf Bromodomain with Small Chemical Ligand Np2
40. 1xiu: Crystal Structure of The Agonist-bound Ligand-binding Domain of Biomphalaria Glabrata Rxr
41. 1ygh: Hat Domain of Gcn5 from Saccharomyces Cerevisiae
42. 1z4r: Human Gcn5 Acetyltransferase
43. 1zaf: Crystal Structure of Estrogen Receptor Beta Complexed with 3-bromo-6-hydroxy-2-(4-hydroxy-phenyl)-inden-1-one
44. 1zoq: Irf3-cbp Complex
45. 1zs5: Structure-based Evaluation of Selective and Non-selective Small Molecules That Block Hiv-1 Tat and Pcaf Association
46. 2a3i: Structural and Biochemical Mechanisms for The Specificity of Hormone Binding and Coactivator Assembly by Mineralocorticoid Receptor
47. 7jfm: Crystal Structure of Mouse Phosphorylated Irf-3 Bound to Cbp
48. 7jfl: Crystal Structure of Human Phosphorylated Irf-3 Bound to Cbp
49. 7co1: Crystal Structure of Smad2 in Complex with Wild-type Cbp
50. 7cmr: The Crystal Structure of Human Myst1 from Wuxi Biortus.
51. 7bq4: X-ray Structure of Human Pparalpha Ligand Binding Domain- Eicosapentaenoic Acid (epa)-src1 Coactivator Peptide Co-crystals Obtained by Delipidation and Co-crystallization
52. 7bq3: X-ray Structure of Human Pparalpha Ligand Binding Domain-gw7647-src1 Coactivator Peptide Co-crystals Obtained by Delipidation and Co- Crystallization
53. 7bq2: X-ray Structure of Human Pparalpha Ligand Binding Domain-pemafibrate- Src1 Coactivator Peptide Co-crystals Obtained by Soaking
54. 7bq1: X-ray Structure of Human Pparalpha Ligand Binding Domain-intrinsic Fatty Acid (e. Coli Origin)-src1 Coactivator Peptide Co-crystals Obtained by Co-crystallization
55. 7bq0: X-ray Structure of Human Pparalpha Ligand Binding Domain-fenofibric Acid-src1 Coactivator Peptide Co-crystals Obtained by Delipidation and Co-crystallization
56. 7bpz: X-ray Structure of Human Pparalpha Ligand Binding Domain-bezafibrate- Src1 Coactivator Peptide Co-crystals Obtained by Soaking
57. 7bpy: X-ray Structure of Human Pparalpha Ligand Binding Domain-clofibric Acid-src1 Coactivator Peptide Co-crystals Obtained by Delipidation and Co-crystallization
58. 6zr5: Crystal Structure of Jnk1 in Complex with Atf2(19-58)
59. 6zqs: Crystal Structure of Double-phosphorylated P38ALPHA with Atf2(83-102)
60. 2ro0: Solution Structure of The Knotted Tudor Domain of The Yeast Histone Acetyltransferase, Esa1
61. 2rnz: Solution Structure of The Presumed Chromodomain of The Yeast Histone Acetyltransferase, Esa1
62. 2rny: Complex Structures of Cbp Bromodomain with H4 Ack20 Peptide
63. 2rnx: The Structural Basis for Site-specific Lysine-acetylated Histone Recognition by The Bromodomains of The Human Transcriptional Co-activators Pcaf and Cbp
64. 2rnw: The Structural Basis for Site-specific Lysine-acetylated Histone Recognition by The Bromodomains of The Human Transcriptional Co-activators Pcaf and Cbp
65. 2rc4: Crystal Structure of The Hat Domain of The Human Moz Protein
66. 2bud: The Solution Structure of The Chromo Barrel Domain from The Males-absent on The First (mof) Protein
67. 2c52: Structural Diversity in Cbp P160 Complexes
68. 2pq8: Myst Histone Acetyltransferase 1
69. 2d82: Target Structure-based Discovery of Small Molecules That Block Human P53 and Creb Binding Protein (cbp) Association
70. 2p54: A Crystal Structure of Ppar Alpha Bound with Src1 Peptide and Gw735
71. 2p0w: Human Histone Acetyltransferase 1 (hat1)
72. 2ozu: Crystal Structure of Human Myst Histone Acetyltransferase 3 in Complex with Acetylcoenzyme a
73. 2ou2: Acetyltransferase Domain of Human Hiv-1 Tat Interacting Protein, 60kda, Isoform 3
74. 6xp9: Structure of Human Pregnane X Receptor Ligand Binding Domain Bound Tethered with Src Co-activator Peptide in Complex with (s,s)-1
75. 6bqd: Taf1-bd2 Bromodomain in Complex with (e)-3-(6-(but-2-en-1-yl)-7-oxo-6, 7-dihydro-1h-pyrrolo[2,3-c]pyridin-4-yl)-n,n-dimethylbenzamide
76. 6bns: Structure of Human Pregnane X Receptor Ligand Binding Domain Bound Tethered with Src Co-activator Peptide and Compound 25a Aka Bicyclic Hexafluoroisopropyl 2 Alcohol Sulfonamides
77. 6ba4: Crystal Structure of Myst Acetyltransferase Domain in Complex with Acetyl-coa Cofactor
78. 6ba2: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor
79. 6ay5: Crebbp Bromodomain in Complex with Cpd17 (5-(7-(difluoromethyl)-6-(1- Methyl-1h-pyrazol-4-yl)-3,4-dihydroquinolin-1(2h)-yl)-3- Methylbenzo[d]thiazol-2(3h)-one)
80. 6ay3: Crebbp Bromodomain in Complex with Cpd16 (5-(7-(difluoromethyl)-6-(1- Methyl-1h-pyrazol-4-yl)-3,4-dihydroquinolin-1(2h)-yl)-n-methyl-1h- Indole-3-carboxamide)
81. 6axq: Crebbp Bromodomain in Complex with Cpd6 (methyl 1h-indole-3- Carboxylate)
82. 2nv7: Crystal Structure of Estrogen Receptor Beta Complexed with Way-555
83. 6alc: Crebbp Bromodomain in Complex with Cpd 4 (1-(1-(cyclopropylmethyl)-3- (1h-indol-4-yl)-1,4,6,7-tetrahydro-5h-pyrazolo[4,3-c]pyridin-5-yl) Ethan-1-one)
84. 6alb: Crebbp Bromodomain in Complex with Cpd 30 (1-(3-(3-(1-methyl-1h- Pyrazol-4-yl)isoquinolin-8-yl)-1-(tetrahydro-2h-pyran-4-yl)-1,4,6,7- Tetrahydro-5h-pyrazolo[4,3-c]pyridin-5-yl)ethan-1-one)
85. 2eko: Solution Structure of Ruh-073, a Pseudo Chromo Domain from Human Cdna
86. 2fvj: A Novel Anti-adipogenic Partial Agonist of Peroxisome Proliferator-activated Receptor-gamma (pparg) Recruits Pparg-coactivator-1 Alpha (PGC1A) but Potentiates Insulin Signaling in Vitro
87. 2giv: Human Myst Histone Acetyltransferase 1
88. 2k8f: Structural Basis for The Regulation of P53 Function by P300
89. 2ka6: Nmr Structure of The Cbp-taz2/stat1-tad Complex
90. 6tfi: Pxr in Complex with Thrombin Inhibitor Compound 17
91. 6t2m: Vdr-zk168281 Complex
92. 6sxx: Crystal Structure of The Bromodomain of Human Crebbp in Complex with Aca007
93. 6sqm: Crystal Structure of Crebbp Bromodomain Complexed with La36
94. 6sqf: Crystal Structure of Crebbp Bromodomain Complexed with LB32A
95. 6sqe: Crystal Structure of Crebbp Bromodomain Complexed with Kd341
96. 6sqc: Crystal Structure of Complex between Nuclear Coactivator Binding Domain of Cbp and [1040-1086]actr Containing Alpha-methylated Leu1055 and Leu1076
97. 2kje: Nmr Structure of Cbp Taz2 and Adenoviral E1A Complex
98. 2kkj: Solution Structure of The Nuclear Coactivator Binding Domain of Cbp
99. 6lsb: Crystal Structure of Dpf Domain of Moz in Complex with H3K14BZ Peptide
100. 6l6k: Crystal Structure of Dimeric Rxralpha-lbd Complexed with Partial Agonist Cbt-pmn and Src1
101. 3p1f: Crystal Structure of The Bromodomain of Human Crebbp in Complex with a Hydroquinazolin Ligand
102. 2l84: Solution Nmr Structures of Cbp Bromodomain with Small Molecule J28
103. 2l85: Solution Nmr Structures of Cbp Bromodomain with Small Molecule of Hbs
104. 3q33: Structure of The Rtt109-accoa/vps75 Complex and Implications for Chaperone-mediated Histone Acetylation
105. 3q35: Structure of The Rtt109-accoa/vps75 Complex and Implications for Chaperone-mediated Histone Acetylation
106. 6p3a: Crystal Structure Analysis of Taf1 Bromodomain
107. 6p39: Crystal Structure Analysis of Taf1 Bromodomain
108. 6p38: Crystal Structure Analysis of Taf1 Bromodomain
109. 3qm0: Crystal Structure of Rtt109-ac-coa Complex
110. 3q66: Structure of The Vps75-rtt109 Histone Chaperone-lysine Acetyltransferase Complex (full-length Proteins in Space Group P6122)
111. 3q68: Structure of The Vps75-rtt109 Histone Chaperone-lysine Acetyltransferase Complex (full-length Proteins in Space Group P212121)
112. 6w9i: Substituted Benzyloxytricyclic Compounds as Retinoic Acid-related Orphan Receptor Gamma T Agonists
113. 6w9h: Substituted Benzyloxytricyclic Compounds as Retinoic Acid-related Orphan Receptor Gamma T Agonists
114. 6yim: Crystal Structure of The Crebbp Bromodomain in Complex with a Benzo- Diazepine Ligand
115. 6yil: Crystal Structure of The Crebbp Bromodomain in Complex with a Tetrahydroquinoxaline Ligand
116. 6yik: Crystal Structure of The Crebbp Bromodomain in Complex with a Tetrahydroquinoxaline Ligand
117. 6yij: Crystal Structure of The Crebbp Bromodomain in Complex with a Benzo- Diazepine Ligand
118. 2kwf: The Structure of E-protein Activation Domain 1 Bound to The Kix Domain of Cbp/p300 Elucidates Leukemia Induction by E2A-PBX1
119. 6v90: Crystal Structure of The P300 Acetyltransferase Domain with Accoa Competitive Inhibitor 12
120. 6v8n: Crystal Structure of The P300 Acetyltransferase Domain with Accoa Competitive Inhibitor 17
121. 6v8k: Crystal Structure of The P300 Acetyltransferase Domain with Peptide- Competitive Inhibitor 2
122. 6v8b: Crystal Structure of The P300 Acetyltransferase Domain with Accoa Competitive Inhibitor 1
123. 6pdg: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor 83
124. 6pdf: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor 55
125. 6pde: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor 40
126. 6pdd: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor 41
127. 6pdc: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor 42
128. 6pdb: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor 80
129. 6pda: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor 74
130. 6pd9: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor 60
131. 6pd8: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor 39
132. 6owi: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor 85
133. 6owh: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor 92
134. 6qst: Structure of Crebbp Bromodomain with Compound 2 Bound
135. 3qah: Crystal Structure of Apo-form Human Mof Catalytic Domain
136. 6vo5: Crystal Structure of Human Histone Acetytransferas 1 (hat1) in Complex with Isobutryl-coa and K12A Mutant Variant of Histone H4
137. 3p57: Crystal Structure of The P300 Taz2 Domain Bound to Mef2 on Dna
138. 3r8d: Activation of The Human Nuclear Xenobiotic Receptor Pxr by The Reverse Transcriptase-targeted Anti-hiv Drug Pnu-142721
139. 6mak: Hbo1 Is Required for The Maintenance of Leukaemia Stem Cells
140. 6maj: Hbo1 Is Required for The Maintenance of Leukaemia Stem Cells
141. 3p89: Fxr Bound to a Quinolinecarboxylic Acid
142. 3rut: Fxr with Src1 and Gsk359
143. 3ruu: Fxr with Src1 and Gsk237
144. 3rvf: Fxr with Src1 and Gsk2034
145. 6u25: Crystal Structure of Rar-related Orphan Receptor C (nhis- Rorgt(244- 487)-l6-src1(678-692)) in Complex with a Tricyclic Inverse Agonist
146. 6ssq: Crystal Structure of Rarbeta Lbd in Complex with Lg 100754
147. 3to6: Crystal Structure of Yeast Esa1 Hat Domain Complexed with H4K16COA Bisubstrate Inhibitor
148. 3to7: Crystal Structure of Yeast Esa1 Hat Domain Bound to Coenzyme a with Active Site Lysine Acetylated
149. 3to9: Crystal Structure of Yeast Esa1 E338Q Hat Domain Bound to Coenzyme a with Active Site Lysine Acetylated
150. 3toa: Human Mof Crystal Structure with Active Site Lysine Partially Acetylated
151. 3tob: Human Mof E350Q Crystal Structure with Active Site Lysine Partially Acetylated
152. 6qpj: Human Clock Pas-a Domain
153. 6qk7: Elongator Catalytic Subcomplex Elp123 Lobe
154. 4a9k: Bromodomain of Human Crebbp with N-(4-hydroxyphenyl) Acetamide
155. 6pgu: Crystal Structure of The P300 Acetyltransferase Domain with Allosteric Inhibitor Cpi-076 and Coa
156. 6pf1: Crystal Structure of The P300 Acetyltransferase Domain with Allosteric Inhibitor Cpi-090 and Coa
157. 3qt0: Revealing a Steroid Receptor Ligand as a Unique Ppargamma Agonist
158. 6p9f: Crystal Structure of Rar-related Orphan Receptor C (nhis-rorgt(244- 487)-l6-src1(678-692)) in Complex with a Phenyl (3-phenylpyrrolidin- 3-yl)sulfone Inhibitor
159. 6oir: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor 62
160. 6oiq: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor 63
161. 6oip: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor 34
162. 6oio: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor 60
163. 6oin: Crystal Structure of Myst Acetyltransferase Domain in Complex with Inhibitor Ctx-124143
164. 6oie: The Double Phd Finger (dpf) of Morf in Complex with Histone H3K14CR
165. 4dm6: Crystal Structure of Rarb Lbd Homodimer in Complex with Ttnpb
166. 4dm8: Crystal Structure of Rarb Lbd in Complex with 9cis Retinoic Acid
167. 4dma: Crystal Structure of Era Lbd in Complex with Ru100132
168. 6o9l: Human Holo-pic in The Closed State
169. 4dk7: Crystal Structure of Lxr Ligand Binding Domain in Complex with Full Agonist 1
170. 4dk8: Crystal Structure of Lxr Ligand Binding Domain in Complex with Partial Agonist 5
171. 6o22: Structure of Asf1-h3:h4-rtt109-vps75 Histone Chaperone-lysine Acetyltransferase Complex with The Histone Substrate.
172. 2lqh: Nmr Structure of FOXO3A Transactivation Domains (CR2C-CR3) in Complex with Cbp Kix Domain (2B3L Conformation)
173. 2lqi: Nmr Structure of FOXO3A Transactivation Domains (CR2C-CR3) in Complex with Cbp Kix Domain (2L3B Conformation)
174. 3t03: Crystal Structure of Ppar Gamma Ligand Binding Domain in Complex with a Novel Partial Agonist Gq-16
175. 6mzl: Human Tfiid Canonical State
176. 6mzd: Human Tfiid Lobe a Canonical
177. 4f3l: Crystal Structure of The Heterodimeric Clock:bmal1 Transcriptional Activator Complex
178. 2ln0: Structure of Moz
179. 3v43: Crystal Structure of Moz
180. 4dnc: Crystal Structure of Human Mof in Complex with Msl1
181. 3t92: Crystal Structure of The Taz2:c/ebpepsilon-tad Chimera Protein
182. 6k4n: Cryo-em Structure of P300
183. 3uu7: Crystal Structure of Hera-lbd (Y537S) in Complex with Bisphenol-a
184. 3uua: Crystal Structure of Hera-lbd (Y537S) in Complex with Bisphenol-af
185. 3uud: Crystal Structure of Hera-lbd (Y537S) in Complex with Estradiol
186. 6jq7: The Ligand-free Structure of Human Ppargamma Lbd in The Presence of The Src-1 Coactivator Peptide
187. 6j3p: Crystal Structure of The Human Gcn5 Bromodomain in Complex with Compound (r,r)-36n
188. 6j3o: Crystal Structure of The Human Pcaf Bromodomain in Complex with Compound 12
189. 4g1y: Structural Basis for The Accommodation of Bis- and Tris-aromatic Derivatives in Vitamin D Nuclear Receptor
190. 4g1z: Structural Basis for The Accommodation of Bis- and Tris-aromatic Derivatives in Vitamin D Nuclear Receptor
191. 4g20: Structural Basis for The Accommodation of Bis- and Tris-aromatic Derivatives in Vitamin D Nuclear Receptor
192. 4g21: Structural Basis for The Accommodation of Bis- and Tris-aromatic Derivatives in Vitamin D Nuclear Receptor
193. 4g2h: Structural Basis for The Accommodation of Bis- and Tris-aromatic Derivatives in Vitamin D Nuclear Receptor
194. 6itm: Crystal Structure of Fxr in Complex with Agonist Xj034
195. 4dqm: Revealing a Marine Natural Product as a Novel Agonist for Retinoic Acid Receptors with a Unique Binding Mode and Antitumor Activity
196. 6ilq: Crystal Structure of Ppargamma with Compound Br101549
197. 6ijs: Human Ppargamma Ligand Binding Domain Complexed with Sb1494
198. 6ijr: Human Ppargamma Ligand Binding Domain Complexed with Sb1495
199. 6if4: Crystal Structure of Tbtudor
200. 6icj: Crystal Structure of Ppargamma with Compound BR102375K
201. 6iaz: The Archaeal Methanocaldococcus Infernus Elp3 with N-terminus Deletion (1-46)
202. 6iad: Apo Crystal Structure of Archaeal Methanocaldococcus Infernus Elp3 (del1-54)
203. 6ia8: Apo Crystal Structure of Archaeal Methanocaldococcus Infernus Elp3 (del1-19)
204. 4h10: Intermolecular Recognition Revealed by The Complex Structure of Human Clock-bmal1 Basic Helix-loop-helix Domains with E-box Dna
205. 6hty: Pxr in Complex with P2X4 Inhibitor Compound 25
206. 6gyt: Transcription Factor Dimerization Activates The P300 Acetyltransferase
207. 6gyr: Transcription Factor Dimerization Activates The P300 Acetyltransferase
208. 4fgy: Identification of a Unique Ppar Ligand with an Unexpected Binding Mode and Antibetic Activity
209. 4i9o: Crystal Structure of Gackix L664C Tethered to 1-10
210. 6gg8: Mineralocorticoid Receptor in Complex with (s)-13
211. 6gev: Mineralocorticoid Receptor in Complex with (s)-13
212. 2lxs: Allosteric Communication in The Kix Domain Proceeds through Dynamic Re-packing of The Hydrophobic Core
213. 2lxt: Allosteric Communication in The Kix Domain Proceeds through Dynamic Re-packing of The Hydrophobic Core
214. 4bcr: Structure of Pparalpha in Complex with Wy14643
215. 6frf: Crystal Structure of Crebbp Bromodomain Complexd with Pa10
216. 6fr0: Crystal Structure of Crebbp Bromodomain Complexd with Pb08
217. 6fqu: Crystal Structure of Crebbp Bromodomain Complexd with Dr09
218. 6fqt: Crystal Structure of Crebbp Bromodomain Complexd with Dr46
219. 6fqo: Crystal Structure of Crebbp Bromodomain Complexd with Dt29
220. 6fo7: Vitamin D Nuclear Receptor Complex 3
221. 6fic: Bivalent Inhibitor Unc4512 Bound to The Taf1 Bromodomain Tandem
222. 6fgs: Solution Structure of P300TAZ2-P73TA1
223. 6fgn: Solution Structure of P300TAZ2-P63TA
224. 4b0a: The High-resolution Structure of Ytbp-ytaf1 Identifies Conserved and Competing Interaction Surfaces in Transcriptional Activation
225. 6f0y: Rtt109 Peptide Bound to Asf1
226. 6es7: Structure and Dynamics Conspire in The Evolution of Affinity between Intrinsically Disordered Proteins
227. 6nx1: Structure of Human Pregnane X Receptor Ligand Binding Domain Bound Tethered with Src Co-activator Peptide and Compound-3 Aka 1,1,1,3,3, 3-hexafluoro-2-{4-[1-(4- Luorobenzenesulfonyl) Cyclopentyl]phenyl}propan-2-ol
228. 2lww: Nmr Structure of Rela-tad/cbp-taz1 Complex
229. 6e24: Ternary Structure of C-myc-tbp-taf1
230. 6e16: Ternary Structure of C-myc-tbp-taf1
231. 6ds6: Crystal Structure of P300 Zz Domain in Complex with Histone H3 Peptide
232. 6dnq: Hbz77 in Complex with Kix and C-myb
233. 6dmx: Hbz56 in Complex with Kix and C-myb
234. 6dmk: A Multiconformer Ligand Model of an Isoxazolyl-benzimidazole Ligand Bound to The Bromodomain of Human Crebbp
235. 2mh0: Solution Nmr Structure of The P300 Taz2:etad1 Complex
236. 6cw3: Crystal Structure of a Yeast Saga Transcriptional Coactivator Ada2/gcn5 Hat Subcomplex, Crystal Form 2
237. 6cw2: Crystal Structure of a Yeast Saga Transcriptional Coactivator Ada2/gcn5 Hat Subcomplex, Crystal Form 1
238. 6ct2: Myst Histone Acetyltransferase KAT6A/B in Complex with Wm-1119
239. 4bhw: Structural Basis for Autoinhibition of The Acetyltransferase Activity of P300
240. 4j5w: Crystal Structure of The Apo-pxr/rxralpha Lbd Heterotetramer Complex
241. 4j5x: Crystal Structure of The Sr12813-bound Pxr/rxralpha Lbd Heterotetramer Complex
242. 4jyg: Crystal Structure of Rarbeta Lbd in Complex with Agonist Bms411 [4- {[(5,5-dimethyl-8-phenyl-5,6-dihydronaphthalen-2-yl) Carbonyl]amino}benzoic Acid]
243. 4jyh: Crystal Structure of Rarbeta Lbd in Complex with Selective Agonist Bms948 [4-{[(8-phenylnaphthalen-2-yl)carbonyl]amino}benzoic Acid]
244. 4jyi: Crystal Structure of Rarbeta Lbd in Complex with Selective Partial Agonist Bms641 [3-chloro-4-[(e)-2-(5,5-dimethyl-8-phenyl-5,6- Dihydronaphthalen-2-yl)ethenyl]benzoic Acid]
245. 4ljn: Crystal Structure of Moz Double Phd Finger
246. 4lk9: Crystal Structure of Moz Double Phd Finger Histone H3 Tail Complex
247. 4lka: Crystal Structure of Moz Double Phd Finger Histone H3K9AC Complex
248. 4llb: Crystal Structure of Moz Double Phd Finger Histone H3K14AC Complex
249. 4n3w: Crystal Structure of The Bromodomain-phd Finger Module of Human Transcriptional Co-activator Cbp in Complex with Acetylated Histone 4 Peptide (H4K20AC).
250. 4n4f: Crystal Structure of The Bromodomain-phd Finger Module of Human Transcriptional Co-activator Cbp in Complex with Di-acetylated Histone 4 Peptide (H412ACK16AC).
251. 4nr4: Crystal Structure of The Bromodomain of Human Crebbp in Complex with an Isoxazolyl-benzimidazole Ligand
252. 4nr5: Crystal Structure of The Bromodomain of Human Crebbp in Complex with an Isoxazolyl-benzimidazole Ligand
253. 4nr6: Crystal Structure of The Bromodomain of Human Crebbp in Complex with an Oxazepin Ligand
254. 4nr7: Crystal Structure of The Bromodomain of Human Crebbp in Complex with an Isoxazolyl-benzimidazole Ligand
255. 4nsq: Crystal Structure of Pcaf
256. 4ouf: Crystal Structure of Cbp Bromodomain
257. 4oy2: Crystal Structure of Taf1-taf7, a Tfiid Subcomplex
258. 5ycp: Human Ppargamma Ligand Binding Domain Complexed with Rosiglitazone
259. 5ycn: Human Ppargamma Ligand Binding Domain Complexed with Lobeglitazone
260. 5y7w: Crystal Structure of The Nco-a1 Pas-b Domain with Yl-2
261. 5xzc: Cryo-em Structure of P300-p53 Protein Complex
262. 5xxh: Crystal Structure Analysis of The Cbp
263. 4psw: Crystal Structure of Histone Acetyltransferase Complex
264. 4psx: Crystal Structure of Histone Acetyltransferase Complex
265. 4pzr: Crystal Structure of P300 Histone Acetyltransferase Domain in Complex with Coenzyme a
266. 4pzs: Crystal Structure of P300 Histone Acetyltransferase Domain in Complex with Acetyl-coenzyme a
267. 4pzt: Crystal Structure of P300 Histone Acetyltransferase Domain in Complex with an Inhibitor, Acetonyl-coenzyme a
268. 5x8w: Crystal Structure of The Mutant Human Ror Gamma Ligand Binding Domain.
269. 5x8u: Crystal Structure of The Wild Human Ror Gamma Ligand Binding Domain.
270. 5x0r: Crystal Structure of Pxr Lbd Complexed with Sjb7
271. 5wci: Human Myst Histone Acetyltransferase 1
272. 5w0q: Crebbp Bromodomain in Complex with Cpd17 (n,2,7-trimethyl-2,3-dihydro- 4h-benzo[b][1,4]oxazine-4-carboxamide)
273. 5w0l: Crebbp Bromodomain in Complex with Cpd10 (1-(3-(7-(difluoromethyl)-6- (1-methyl-1h-pyrazol-4-yl)-3,4-dihydroquinolin-1(2h)-yl)-1- (tetrahydro-2h-pyran-4-yl)-1,4,6,7-tetrahydro-5h-pyrazolo[4,3- C]pyridin-5-yl)ethan-1-one)
274. 4qqg: Crystal Structure of an N-terminal Htatip Fragment
275. 5w0i: Crebbp Bromodomain in Complex with Cpd8 (1-(3-(7-(difluoromethyl)-6- (1-methyl-1h-pyrazol-4-yl)-3,4-dihydroquinolin-1(2h)-yl)-1- (tetrahydrofuran-3-yl)-1,4,6,7-tetrahydro-5h-pyrazolo[4,3-c]pyridin- 5-yl)ethan-1-one)
276. 5w0f: Crebbp Bromodomain in Complex with Cpd3 ((s)-1-(3-(6-(1-methyl-1h- Pyrazol-4-yl)-3,4-dihydroquinolin-1(2h)-yl)-1-(tetrahydrofuran-3-yl)- 1,4,6,7-tetrahydro-5h-pyrazolo[4,3-c]pyridin-5-yl)ethan-1-one)
277. 5w0e: Crebbp Bromodomain in Complex with Cpd19 (3-(7-(difluoromethyl)-6-(1- Methyl-1h-pyrazol-4-yl)-3,4-dihydroquinolin-1(2h)-yl)-n-methyl-1- (tetrahydro-2h-pyran-4-yl)-1,4,6,7-tetrahydro-5h-pyrazolo[4,3- C]pyridine-5-carboxamide)
278. 6ktm: The Ligand-free Structure of Human Ppargamma Ligand-binding Domain R288A Mutant in The Presence of The Src-1 Coactivator Peptide
279. 6ktn: Human Ppargamma Ligand-binding Domain R288A Mutant in Complex with Imatinib
280. 5vjx: Crystal Structure of The Clock Transcription Domain Exon19 in Complex with a Repressor
281. 5vji: Crystal Structure of The Clock Transcription Domain Exon19 in Complex with a Repressor
282. 4rgw: Crystal Structure of a Taf1-taf7 Complex in Human Transcription Factor Iid
283. 5u2j: Morf Double Phd Finger (dpf) in Complex with Histone H3K14BU
284. 5trm: Crystal Structure of Human Gcn5 Histone Acetyltransferase Domain
285. 5trl: Crystal Structure of Human Gcn5 Histone Acetyltransferase Domain
286. 5tpx: Bromodomain from Plasmodium Faciparum Gcn5, Complexed with Compound
287. 5tb6: Structure of Bromodomain of Crebbp with a Pyrazolo[4,3-c]pyridin Fragment
288. 5svh: Crystal Structure of The Kix Domain of Cbp in Complex with a Mll/c-myb Chimera
289. 5owk: Crystal Structure of Crebbp Bromodomain Complexed with DSPB2A002
290. 5owd: Vitamin D Receptor Complex
291. 5ow9: Vitamin D Receptor Complex
292. 5ow7: Vdr Complex
293. 5nwx: Insight into The Molecular Recognition Mechanism of The Coactivator Ncoa1 by Stat6
294. 5nwm: Insight into The Molecular Recognition Mechanism of The Coactivator Ncoa1 by Stat6
295. 5nu5: Crystal Structure of The Human Bromodomain of Ep300 Bound to The Inhibitor Xdm-cbp
296. 5nu3: Crystal Structure of The Human Bromodomain of Crebbp Bound to The Inhibitor Xdm-cbp
297. 5nrw: Crystal Structure of The Human Bromodomain of Crebbp Bound to The Inhibitor Xdm4
298. 5nma: Structure-activity Relationship Study of Vitamin D Analogs with Oxolane Group in Their Side Chain
299. 5nlk: Crystal Structure of Crebbp Bromodomain Complexd with US13A
300. 5mqk: Crystal Structure of Crebbp Bromodomain Complexed with Cbp019
301. 5mqg: Crystal Structure of Crebbp Bromodomain Complexed with Cbp015
302. 5mqe: Crystal Structure of Crebbp Bromodomain Complexed with Cbp006
303. 5mpz: Crystal Structure of Crebbp Bromodomain Complexed with Cbp007
304. 5mpn: Crystal Structure of Crebbp Bromodomain Complexed with Fa26
305. 5mpk: Crystal Structure of Crebbp Bromodomain Complexed with Dk19
306. 5mmg: Crystal Structure of Crebbp Bromodomain Complexed with UT07C
307. 5mme: Crystal Structure of Crebbp Bromodomain Complexd with US46C
308. 5mlj: Bromodomain of Human Gcn5 with 4-bromo-2-methyl-5-(((3r,5r)-1-methyl- 5-phenylpiperidin-3-yl)amino)pyridazin-3(2h)-one
309. 5ml0: Bromodomain of Mouse Pcaf with (r)-4-chloro-2-methyl-5-((1- Methylpiperidin-3-yl)amino)pyridazin-3(2h)-one
310. 5mkx: 1.68a Structure Pcaf Bromodomain with 4-chloro-2-methyl-5- (methylamino)pyridazin-3(2h)-one
311. 5mg2: Crystal Structure of The Second Bromodomain of Human Taf1 in Complex with Bay-299 Chemical Probe
312. 5lvr: Crystal Structure of Human Pcaf Bromodomain in Complex with Compound-e (cpd-e)
313. 5lvq: Crystal Structure of Human Pcaf Bromodomain in Complex with Compound-d (cpd-d), N-methyl-2-(tetrahydro-2h-pyran-4-yloxy)benzamide
314. 5lpm: Crystal Structure of The Bromodomain of Human Ep300 Bound to The Inhibitor XDM3D
315. 5lpl: Crystal Structure of The Bromodomain of Human Crebbp Bound to The Inhibitor XDM3C
316. 5lpk: Crystal Structure of The Bromodomain of Human Ep300 Bound to The Inhibitor Xdm1
317. 5lpj: Crystal Structure of The Bromodomain of Human Crebbp Bound to The Inhibitor Xdm1
318. 5lkz: Crystal Structure of The P300 Acetyltransferase Catalytic Core with Crotonyl-coenzyme A.
319. 5lkx: Crystal Structure of The P300 Acetyltransferase Catalytic Core with Propionyl-coenzyme A.
320. 5lku: Crystal Structure of The P300 Acetyltransferase Catalytic Core with Coenzyme A.
321. 5lkt: Crystal Structure of The P300 Acetyltransferase Catalytic Core with Butyryl-coenzyme A.
322. 5ktx: Crebbp Bromodomain in Complex with Cpd59 ((s)-1-(3-((2-fluoro-4-(1- Methyl-1h-pyrazol-4-yl)phenyl)amino)-1-(tetrahydrofuran-3-yl)-6,7- Dihydro-1h-pyrazolo[4,3-c]pyridin-5(4h)-yl)ethanone)
323. 5ktw: Crebbp Bromodomain in Complex with Cpd 44 (3-((5-acetyl-1- (cyclopropylmethyl)-4,5,6,7-tetrahydro-1h-pyrazolo[4,3-c]pyridin-3- Yl)amino)-n-isopropylbenzamide)
324. 5ktu: Crystal Structure of The Bromodomain of Human Crebbp Bound to Pyrazolopiperidine Scaffold
325. 5kj2: The Novel P300/cbp Inhibitor A-485 Uncovers a Unique Mechanism of Action to Target Ar in Castrate Resistant Prostate Cancer
326. 5jmm: Crystal Structure of Hera-lbd (Y537S) in Complex with Biochanin a
327. 5ji0: PPARGAMMA-RXRALPHA(S427F) Heterodimer in Complex with Src-1, Rosiglitazone, and 9-cis-retanoic Acid
328. 5jem: Complex of Irf-3 with Cbp
329. 5j9w: Crystal Structure of The Nua4 Core Complex
330. 5j9u: Crystal Structure of The Nua4 Core Complex
331. 5j9t: Crystal Structure of The Nua4 Core Complex
332. 5j9q: Crystal Structure of The Nua4 Core Complex
333. 5j8f: Human Mof K274P Crystal Structure
334. 5j8c: Human Mof C316S, E350Q Crystal Structure
335. 5j0d: Crystal Structure of The Bromodomain of Human Crebbp in Complex with a Benzoxazepine Compound
336. 5icw: Crystal Structure of Human Natf (hnaa60) Homodimer Bound to Coenzyme a
337. 5icv: Crystal Structure of Human Natf (hnaa60) Bound to a Bisubstrate Analogue
338. 5i8g: Cbp in Complex with Cpd637 ((r)-4-methyl-6-(1-methyl-3-(1-methyl-1h- Pyrazol-4-yl)-1h-indazol-5-yl)-1,3,4,5-tetrahydro-2h-benzo[b][1, 4]diazepin-2-one)
339. 5i8b: Cbp in Complex with Cpd23 ((r)-6-(3-(benzyloxy)phenyl)-4-methyl-1,3,4, 5-tetrahydro-2h-benzo[b][1,4]diazepin-2-one)
340. 5hpd: Solution Structure of TAZ2-P53TAD
341. 5hp0: Solution Structure of TAZ2-P53AD2
342. 5hou: Solution Structure of P53TAD-TAZ1
343. 5hjs: Identification of Lxrbeta Selective Agonists for The Treatment of Alzheimer's Disease
344. 5hh1: Crystal Structure of Human Naa60 Mutant - F34A in Complex with Coa
345. 5hh0: Crystal Structure of Human Naa60 in Complex with Coa
346. 5hgz: Crystal Structure of Human Naa60 in Complex with Acetyl-coa
347. 5h86: Human Gcn5 Bound to Butyryl-coa
348. 5h85: Crystal Structure of The Bromodomain of Human Crebbp in Complex with UO37D
349. 5h84: Human Gcn5 Bound to Propionyl-coa
350. 5h43: Structural and Mechanistical Studies of The Nuclear Import by Importin-alpha
351. 5gk9: Crystal Structure of Human Hbo1 in Complex with Brpf2
352. 5fur: Structure of Human Tfiid-iia Bound to Core Promoter Dna
353. 5fe9: Crystal Structure of Human Pcaf Bromodomain in Complex with Compound Sl1122 (compound 13)
354. 5fe8: Crystal Structure of Human Pcaf Bromodomain in Complex with Compound Sl1126 (compound 12)
355. 5fe7: Crystal Structure of Human Pcaf Bromodomain in Complex with Fragment Zb2216 (fragment 11)
356. 5fe6: Crystal Structure of Human Pcaf Bromodomain in Complex with Fragment Zb1916 (fragment 10)
357. 5fe5: Crystal Structure of Human Pcaf Bromodomain in Complex with Fragment Mb093 (fragment 7)
358. 5fe4: Crystal Structure of Human Pcaf Bromodomain in Complex with Fragment Mb364 (fragment 5)
359. 5fe3: Crystal Structure of Human Pcaf Bromodomain in Complex with Fragment Mb360 (fragment 4)
360. 5fe2: Crystal Structure of Human Pcaf Bromodomain in Complex with Fragment Br013 (fragment 3)
361. 5fe1: Crystal Structure of Human Pcaf Bromodomain in Complex with Fragment Br004 (fragment 1)
362. 5fe0: Crystal Structure of Human Pcaf Bromodomain in Complex with Acetyllysine
363. 5fdz: Crystal Structure of Human Pcaf Bromodomain in Complex with Compound BDOMB00091A (compound 14)
364. 5ep7: Crystal Structure of The Bromodomain of Human Crebbp in Complex with Un32
365. 5eng: Crystal Structure of The Bromodomain of Human Crebbp in Complex with Up39
366. 5eic: Crystal Structure of The Bromodomain of Human Crebbp in Complex with Ayc
367. 5dwl: Human Ppargamma Ligand Binding Dmain in Complex with Sr1664
368. 5dvc: Human Ppargamma Ligand Binding Dmain Complexed with Sb1453 in a Covalent Bonded Form
369. 5dv8: Human Ppargamma Ligand Binding Dmain Complexed with Sb1451 in a Covalent Bonded Form
370. 5dv6: Human Ppargamma Ligand Binding Dmain Complexed with Sb1404 in a Covalent Bonded Form
371. 5dv3: Human Ppargamma Ligand Binding Dmain Complexed with Sb1405 in a Covalent Bonded Form
372. 5dsh: Human Ppargamma Ligand Binding Dmain Complexed with Sb1406 in a Covalent Bonded Form
373. 5dbm: Crystal Structure of The Cbp Bromodomain in Complex with Cpi703
374. 5cgp: Selective Pharmacological Inhibition of The Creb Binding Protein Bromodomain Regulates Inflammatory Cytokines in Macrophages and Rgs4 in Neurons
375. 4ci4: Structural Basis for Gl479 a Dual Peroxisome Proliferator- Activated Receptor Alpha Agonist
376. 5bt3: Crystal Structure of Ep300 Bromodomain in Complex with Sgc-cbp30 Chemical Probe
377. 5b78: Crystal Structure of Moz Double Phd Finger MUTANT-S210D/N235R in Complex with Histone H3 Crotonylation at K14
378. 5b77: Crystal Structrue of Moz Double Phd Finger in Complex with Histone H3 Propionylation at K14
379. 5b76: Crystal Structure of Moz Double Phd Finger Domain in Complex with Histone H3 Crotonylation at K14
380. 5b75: Crystal Structure of Moz Double Phd Finger in Complex with Histone H3 Butyrylation at K14
381. 5avl: Crystal Structure of Lxralpha in Complex with Tert-butyl Benzoate Analog, Compound 32b
382. 5avi: Crystal Structure of Lxralpha in Complex with Tert-butyl Benzoate Analog, Compound 4
383. 5a86: Structure of Pregnane X Receptor in Complex with a Sphingosine 1- Phosphate Receptor 1 Antagonist
384. 4tuz: Crystal Structure of Hera-lbd (Y537S) in Complex with Alpha-zearalenol
385. 4tv1: Crystal Structure of Hera-lbd (Y537S) in Complex with Propylparaben
386. 2mzd: Characterization of The P300 Taz2-p53 Tad2 Complex and Comparison with The P300 Taz2-p53 Tad1 Complex
387. 4yk0: Crystal Structure of The Cbp Bromodomain in Complex with Cpi098
388. 2n1a: Docked Structure between Sumo1 and Zz-domain from Cbp
389. 4tqn: Crystal Structure of The Bromodomain of Human Crebbp in Complex with Ul04
390. 4ts8: Crystal Structure of The Bromodomain of Human Crebbp in Complex with Xz08
391. 4uda: Mr in Complex with Dexamethasone
392. 4udb: Mr in Complex with Desisobutyrylciclesonide
393. 4whu: Bromo Domain of Creb Binding Protein
394. 7kxd: Crystal Structure of Rar-related Orphan Receptor C (nhis-rorgt(244- 487)-l6-src1(678-692)) in Complex with {3,5-dichloro-4-[4-methoxy-3- (propan-2-yl)phenoxy]phenyl}methanol
395. 7kxe: Crystal Structure of Rar-related Orphan Receptor C (nhis-rorgt(244- 487)-l6-src1(678-692)) in Complex with {3,5-dichloro-4-[4-methoxy-3- (propan-2-yl)phenoxy]phenyl}methanol
396. 7kxf: Crystal Structure of Rar-related Orphan Receptor C (nhis-rorgt(244- 487)-l6-src1(678-692)) in Complex with {3,5-dichloro-4-[4-methoxy-3- (propan-2-yl)phenoxy]phenyl}methanol
397. 7jjh: Crystal Structure of The Unliganded Tandem Bromodomain (bd1, Bd2) of Human Taf1
398. 7lje: Discovery of Spirohydantoins as Selective, Orally Bioavailable Inhibitors of P300/cbp Histone Acetyltransferases
399. 7bwz: Crystal Structure of Rtt109 from Candida Albicans
400. 7bx0: Crystal Structure of Rtt109 from Candida Albicans
401. 7bx1: Crystal Structure of Rtt109 from Candida Albicans
402. 7bxw: Crystal Structure off Rtt109 from Candida Albicans
403. 7edx: P53-bound Tfiid-based Core Pic on Hdm2 Promoter
404. 7eg7: Tfiid-based Core Pic on Scp Promoter
405. 7eg8: Tfiid-based Core Pic on Puma Promoter
406. 7eg9: Tfiid-based Intermediate Pic on Scp Promoter
407. 7ega: Tfiid-based Intermediate Pic on Puma Promoter
408. 7nvr: Human Mediator with Rna Polymerase II Pre-initiation Complex
409. 7nvs: Rna Polymerase II Core Pre-initiation Complex with Closed Promoter Dna in Proximal Position
410. 7nvt: Rna Polymerase II Core Pre-initiation Complex with Closed Promoter Dna in Distal Position
411. 7nvu: Rna Polymerase II Core Pre-initiation Complex with Open Promoter Dna
412. 7nvy: Rna Polymerase II Pre-initiation Complex with Closed Promoter Dna in Proximal Position
413. 7nvz: Rna Polymerase II Pre-initiation Complex with Closed Promoter Dna in Distal Position
414. 7nw0: Rna Polymerase II Pre-initiation Complex with Open Promoter Dna
415. 7egd: Scp Promoter-bound Tfiid-tfiia in Initial Tbp-loading State
416. 7ege: Tfiid in Canonical Conformation
417. 7egh: Tfiid Lobe C Subcomplex
418. 7egi: Tfiid in Rearranged Conformation
419. 7egj: Scp Promoter-bound Tfiid-tfiia in post Tbp-loading State
420. 7c3o: Crystal Structure of Tt109 from Candida Albicans
421. 7kpy: Crystal Structure of Cbp Bromodomain Liganded with Umb298 (compound 23)
422. 7n42: Crystal Structure of The Tandem Bromodomain of Human Taf1 (taf1-t) Bound to Zs1-681
423. 7l6x: Crystal Structure of The Tandem Bromodomain (bd1, Bd2) of Human Taf1 Bound to Gne-371
424. 7chg: The Structure of Human Pregnane X Receptor in Complex with an Src-1 Coactivator Peptide and a Limonoid Compound
425. 7d0o: Crystal Structure of Human Hbo1-brpf2 in Apo Form
426. 7d0p: Crystal Structure of Human Hbo1-brpf2 in Complex with Propionyl- Coenzyme a
427. 7d0q: Crystal Structure of Human Hbo1-brpf2 in Complex with Butyryl-coenzyme a
428. 7d0r: Crystal Structure of Human Hbo1-brpf2 in Complex with Crotonoyl- Coenzyme a
429. 7d0s: Crystal Structure of Human Hbo1-brpf2 in Complex with Succinyl- Coenzyme a
430. 7lb0: Crystal Structure of The Tandem Bromodomain (bd1, Bd2) of Human Taf1 Bound to Zs1-295
431. 7lb1: Crystal Structure of The Tandem Bromodomain (bd1, Bd2) of Human Taf1 Bound to Zs1-585
432. 7lb2: Crystal Structure of The Tandem Bromodomain (bd1, Bd2) of Human Taf1 Bound to Zs1-589
433. 7jjg: Crystal Structure of The Second Bromodomain (bd2) of Human Taf1 Bound to Atr Kinase Inhibitor Az20
434. 7lvs: The Cbp Taz1 Domain in Complex with a Cited2-hif-1-alpha Fusion Peptide
435. 7aos: Crystal Structure of The Raralpha/rxralpha Ligand Binding Domain Heterodimer in Complex with a Fragment of Src1 Coactivator
436. 7bo6: Vdr Complex with Lca Derivative
437. 7jsp: Crystal Structure of The Second Bromodomain (bd2) of Human Taf1 Bound to Atr Kinase Inhibitor Azd6738
438. 7jtc: Crystal Structure of The Second Bromodomain (bd2) of Human Taf1 Bound to Zs1-322
439. 7b39: Allene-based Design of a Noncalcemic Vitamin D Receptor Agonist
440. 7cxf: The Ligand-free Structure of Human Ppargamma Lbd C285Y Mutant in The Presence of The Src-1 Coactivator Peptide
441. 7cxh: The Ligand-free Structure of Human Ppargamma Lbd Q286E Mutant in The Presence of The Src-1 Coactivator Peptide
442. 7cxi: The Ligand-free Structure of Human Ppargamma Lbd F287Y Mutant in The Presence of The Src-1 Coactivator Peptide
443. 7cxj: The Ligand-free Structure of Human Ppargamma Lbd R288C Mutant in The Presence of The Src-1 Coactivator Peptide
444. 7cxk: The Ligand-free Structure of Human Ppargamma Lbd R288H Mutant in The Presence of The Src-1 Coactivator Peptide
445. 7cxl: The Ligand-free Structure of Human Ppargamma Lbd S289C Mutant in The Presence of The Src-1 Coactivator Peptide
446. 7juo: Cbp Bromodomain Complexed with Yf2-23
447. 7oxz: Vdr Complex with a Side-chain Hydroxylated Derivative of Lithocholic Acid
448. 7oy4: Vdr Complex of a Side-chain Hydroxylated Derivatives of Lithocholic Acid
449. 7k03: Crystal Structure of The Tandem Bromodomain (bd1 and Bd2) of Human Taf1 Bound to Atr Kinase Inhibitor Azd6738
450. 7k0d: Crystal Structure of The Tandem Bromodomain (bd1, Bd2) of Human Taf1 Bound to Mtorc1/2 Inhibitor Azd3147
451. 7k0u: Crystal Structure of The Second Bromodomain (bd2) of Human Taf1 Bound to Plk1 Kinase Inhibitor Bi2536
452. 7k1p: Crystal Structure of The Second Bromodomain (bd2) of Human Taf1 Bound to Bromosporine
453. 7k27: Crystal Structure of The Tandem Bromodomain (bd1, Bd2) of Human Taf1 Bound to Atr Inhibitor Az20
454. 7k3o: Crystal Structure of The Unliganded Second Bromodomain (bd2) of Human Taf1
455. 7k42: Crystal Structure of The Second Bromodomain (bd2) of Human Taf1 Bound to Dioxane
456. 7k6f: Crystal Structure of The Tandem Bromodomain (bd1, Bd2) of Human Taf1 in Complex with Mes (2-(n-morpholino)ethanesulfonic Acid)
457. 7p4s: Bromodomain of Human Taf1 (2) with Naphthyridinone Compound